| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/24/2001 | CN1281046A Human growth or deformation dependent protein and its coding sequence |
| 01/24/2001 | CN1281045A Human fibrous surface structure subunit protein and its coding sequence |
| 01/24/2001 | CN1281044A Human translation initiation factor protein and its coding sequence |
| 01/24/2001 | CN1281043A Human early endosome antigen protein isomer and its coding sequence |
| 01/24/2001 | CN1281042A Human carboxylpeptidase protein and its coding sequence |
| 01/24/2001 | CN1281041A Human complement component subunit chain protein isomer and its coding sequence |
| 01/24/2001 | CN1281040A Human actin associated protein compound subunit protein and its coding sequence |
| 01/24/2001 | CN1281039A Human ribosome subunit protein and its coding sequence |
| 01/24/2001 | CN1280985A Recombined human hopatocyte auxin, its preparing process and its clinical application |
| 01/24/2001 | CN1280984A Process for preparing recombined human interleukin-11 by use of hydroxylamine to cut fusion protein |
| 01/24/2001 | CN1280983A Derivant of interleukin-11 and its preparing process |
| 01/24/2001 | CN1061098C Anti-microbial agents and screening method |
| 01/24/2001 | CN1061093C Incasing cell series for prodn. of recombined adenovirus accompanying virus, and application thereof |
| 01/24/2001 | CN1061092C Component of white monilia with reverse transcription transposons structure |
| 01/24/2001 | CN1061091C Construction method of gene probe using chlorophyll molecule as connexon |
| 01/24/2001 | CN1061089C Pullulanase, microorganisms which produce it, processes for preparation of this pullulanase and uses thereof |
| 01/23/2001 | US6177616 Genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and their use |
| 01/23/2001 | US6177615 Lepidopteran-toxic polypeptide and polynucleotide compositions and methods for making and using same |
| 01/23/2001 | US6177614 Nucleotide sequences coding polypeptide associated with flowering; for efficient propagation of maize and sorghum hybrids |
| 01/23/2001 | US6177613 Regulatory sequences associated with the transcription of heterologous nucleotide sequences in plants |
| 01/23/2001 | US6177612 Nucleotide sequences associated with binding nuclear proteins; for transforming monocotyledonous crop plants and stabilization of transgene expression |
| 01/23/2001 | US6177611 Nucleotide sequences associated with activation of transcription in plants; for consistent expression of heterologous nucleotide sequences in plants |
| 01/23/2001 | US6177610 Expression vector coding preferential rodent polypeptide; for use in the treatment of allergic inflammation and asthma |
| 01/23/2001 | US6177559 Separating polynucleotides using nonpolar beads, a counterion agent and stripping solvent to release selected polynucleotide fragments from the beads |
| 01/23/2001 | US6177558 During solid phase synthesis of nucleic acids, peptides and peptide nucleic acids on an open environment solid support, the polar aprotic solvent selected from mono- and dinitriles, glymes, diglymes, triglymes, and trimethylphosphates |
| 01/23/2001 | US6177557 Nucleotide sequences which bind preferential proteins; for use as coagulants and in prevention of neovascularization |
| 01/23/2001 | US6177556 Nucleotide sequences coding stem cell factor protein; for use in in vitro fertilization therapy |
| 01/23/2001 | US6177554 Nucleic acid transporter systems |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177545 Antibody which preferentially binds an epitope of an enzymatic protein; for diagnosis of time events in tumor propagation and metastasis, autoimmune diseases, kidney defects and atherosclerotic injury |
| 01/23/2001 | US6177543 Homogeneous human lymphokines; for the treatment of tumors; antitumor agents |
| 01/23/2001 | US6177414 Polymaminoamide dendrimer star polymer carrying salicylic acid moieties; drug delivery |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177278 Nucleic acid purification and process |
| 01/23/2001 | US6177275 Plant nitrogen regulatory P-PII genes |
| 01/23/2001 | US6177274 Expression vector for transfering nucleotide sequences to liver cells; for the amplified efficiency of transformation and transfection of preferential cells |
| 01/23/2001 | US6177273 Antisense modulation of integrin-linked kinase expression |
| 01/23/2001 | US6177272 Method for treating vascular proliferative diseases with p27 and fusions thereof |
| 01/23/2001 | US6177270 Reaction-based selection for expression of and concentration of catalytic moieties |
| 01/23/2001 | US6177267 Amino acid sequence of acetyl-coenzyme a carboxylase; for transgenic plants with increased or decreased herbicide resistance; for screening samples for herbicide resistance |
| 01/23/2001 | US6177264 Nucleotide sequences isolated from coryneform which code for ketopantoate hydroxymethyltransferase and pantothenate synthetase of defined amino acid sequences; for recombinant production |
| 01/23/2001 | US6177263 Simple and efficient method for in vitro mutagenesis and recombination of polynucleotide sequences based on based on polymerase-catalyzed extension of primer oligonucleotides |
| 01/23/2001 | US6177261 Promoter activated by regulator and linked to desired protein or peptide and a nucleotide sequence including a promoter and encoding the regulator; regulator is fungal xylanolytic regulator, xylr; obtaining metabolic mutant microorganisms |
| 01/23/2001 | US6177258 Amino acid sequences of protein; for screening enzyme inhibitors for use as parasiticides/insecticides; veterinary medicine |
| 01/23/2001 | US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/23/2001 | US6177254 Nucleolus autoantigenic marker for systemic lupus erthyematosus |
| 01/23/2001 | US6177251 Separating mammalian nucleic acid from sample by removing particulate matter from sample in a lysis buffer, then separating out nucleic acids; buffer does not lyse bacterial cells; screening for mutation in gene indicative of cancer |
| 01/23/2001 | US6177250 Nucleic acid mediated electron transfer |
| 01/23/2001 | US6177249 Kit includes a polynucleotide and a dideoxynucleotide labeled with fluorescent dyes; emission spectrum of one overlaps the excitation spectrum of the other; simple, automatic, accurate diagnosis, paternity testing, forensics, genotyping |
| 01/23/2001 | US6177248 Detecting expression of at least one gene down-stream from wt1 and comparing to wild type cells; a difference suggests mutation; diagnosis of cancer/tumor |
| 01/23/2001 | US6177246 Contacting a tissue or cell with an oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding abnormally expressed beta-amyloid precursor protein; prophylaxis and treatment of alzheimer's disease |
| 01/23/2001 | US6177245 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 01/23/2001 | US6177244 Oligonucleotide which hybridizes to nucleic acid of defined nucleotide sequence; diagnosis; drug screening; antitumor agents; antimetastasis agents |
| 01/23/2001 | US6177243 Nucleic acid sequence detection employing amplification probes |
| 01/23/2001 | US6177242 Genomic DNA fragments containing regulatory and coding sequences for the β2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
| 01/23/2001 | US6177241 Use of peptides to improve specificity of an immunoassay for the detection of cytomegalovirus specific IgM antibody |
| 01/23/2001 | US6177086 DNA molecule conferring on Mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates |
| 01/23/2001 | US6177082 Cold-adapted equine influenza viruses |
| 01/23/2001 | US6177081 Human and marmoset activating viruses |
| 01/23/2001 | US6177080 Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy |
| 01/23/2001 | US6177079 Monoclonal antibodies against interleukins |
| 01/23/2001 | US6177075 Insect viruses and their uses in protecting plants |
| 01/23/2001 | US6176990 Micro-electrophoresis chip for moving and separating nucleic acids and other charged molecules |
| 01/23/2001 | CA2045323C Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide |
| 01/19/2001 | WO2001005981A1 Genes coding for flavone synthases |
| 01/19/2001 | CA2324228A1 Genes coding for flavone synthases |
| 01/18/2001 | WO2001004613A1 Microfabricated injector and capillary array assembly for high-resolution and high throughput separations |
| 01/18/2001 | WO2001004361A2 Detection of hiv-1 by nucleic acid amplification |
| 01/18/2001 | WO2001004360A2 Retroviral recombination assays and uses thereof |
| 01/18/2001 | WO2001004359A1 Prophage dna sequences and their use in determining instability in lactobacilli cultures |
| 01/18/2001 | WO2001004358A2 Detection of anti-hepatitis b drug resistance |
| 01/18/2001 | WO2001004354A2 Use of ras inhibitors of inhibiting muscle atrophy |
| 01/18/2001 | WO2001004351A2 Genetic test for detecting a predisposition to a disease associated with abnormal vegf gene expression |
| 01/18/2001 | WO2001004350A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 01/18/2001 | WO2001004344A2 Induction of a th1-like response in vitro |
| 01/18/2001 | WO2001004341A1 Method for producing oligopolysaccharides |
| 01/18/2001 | WO2001004335A2 Human-bovine chimeric respiratory syncytial virus vaccines |
| 01/18/2001 | WO2001004334A2 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 01/18/2001 | WO2001004333A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 01/18/2001 | WO2001004332A1 Method to improve viral infection |
| 01/18/2001 | WO2001004331A2 Enhanced expression of proteins using gfp |
| 01/18/2001 | WO2001004330A1 Identification and overexpression of a dna sequence coding for 2-methyl-6-phytylhydroquinone-methyltransferase in plants |
| 01/18/2001 | WO2001004329A1 Modified human granulocyte-colony stimulating factor and process for producing same |
| 01/18/2001 | WO2001004328A1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 01/18/2001 | WO2001004327A1 Expression of herbicide tolerance genes in plant plastids |
| 01/18/2001 | WO2001004326A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 01/18/2001 | WO2001004325A1 Nucleotide sequences for the tal gene |
| 01/18/2001 | WO2001004324A1 Method for preparing 1,3-propanediol by a recombinant micro-organism in the absence of coenzyme b12 or one of its precursors |
| 01/18/2001 | WO2001004323A2 11-arachidonate-lipoxygenase mutants |
| 01/18/2001 | WO2001004322A1 Nucleotide sequences which code for the opca gene |
| 01/18/2001 | WO2001004321A1 Production of attenuated respiratory syncytial virus vaccines involving modification of m2 orf2 |
| 01/18/2001 | WO2001004320A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | WO2001004319A1 Mosaic infectious bursal disease virus vaccines |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004317A1 Ompa gene for an outer membrane protein of riemerella anatipestifer and methods of use |
| 01/18/2001 | WO2001004316A2 Antigenic meningococcal peptides |
| 01/18/2001 | WO2001004315A2 Ringene compositions and methods for use thereof |
| 01/18/2001 | WO2001004314A2 Nucleic acid molecules and proteins associated with sterol synthesis and metabolism |
| 01/18/2001 | WO2001004313A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | WO2001004312A1 Proliferation differentiation factor |